Insiders · Profile

Gould Robert J

Director at Fulcrum Therapeutics. Filing since 19 Feb 2020. CIK 0001577034

Company
Date
Role
Action
Shares
Amount
Of holding
2 Feb 2026
Director
Sold at will
15,000
$160.86K
3.2%
2 Jan 2026
Director
Sold at will
15,000
$178.09K
3.1%
19 Nov 2025
Director
Sold at will
15,000
$165.50K
3.0%
13 Jan 2023
Interim President & CEO
Sold, plan not stated
6,766
$101.49K
1.3%
7 Jun 2022
Director
Sold, plan not stated
71,435
$577.89K
12.4%
6 Jun 2022
Director
Sold, plan not stated
24,382
$197.59K
4.6%
3 Jun 2022
Director
Sold, plan not stated
25,551
$203.06K
4.8%
2 Jun 2022
Director
Sold, plan not stated
16,689
$132.16K
3.2%
7 Apr 2022
Director
Sold, plan not stated
5,631
$135.23K
1.1%
5 Apr 2022
Director
Sold, plan not stated
52,552
$1.27M
9.4%
4 Apr 2022
Director
Sold, plan not stated
7,235
$173.75K
1.4%
1 Apr 2022
Director
Sold, plan not stated
34,464
$828.16K
6.4%
16 Mar 2021
See Remarks
Sold, plan not stated
789
$9.81K
0.2%
15 Mar 2021
See Remarks
Sold, plan not stated
9,211
$111.77K
1.8%
16 Feb 2021
See Remarks
Sold, plan not stated
8,215
$117.20K
1.6%
20 Jan 2021
See Remarks
Sold, plan not stated
10,000
$120.83K
1.9%
8 Jul 2020
See Remarks
Sold, plan not stated
2,500
$50.00K
0.5%
25 Jun 2020
See Remarks
Sold, plan not stated
2,500
$51.99K
0.5%
9 Jun 2020
See Remarks
Sold, plan not stated
156
$3.12K
0.0%
5 Jun 2020
See Remarks
Sold, plan not stated
3,433
$69.25K
0.6%
4 Jun 2020
See Remarks
Sold, plan not stated
1,300
$26.06K
0.2%
3 Jun 2020
See Remarks
Sold, plan not stated
1,500
$30.19K
0.3%
2 Jun 2020
See Remarks
Sold, plan not stated
2,797
$55.94K
0.5%
1 Jun 2020
See Remarks
Sold, plan not stated
5
$100.00
0.0%
29 May 2020
See Remarks
Sold, plan not stated
1,390
$27.91K
0.3%
28 May 2020
See Remarks
Sold, plan not stated
1,919
$38.39K
0.3%
26 May 2020
See Remarks
Sold, plan not stated
2,500
$50.00K
0.5%
19 Feb 2020
See Remarks
Sold, plan not stated
2,500
$50.00K
0.4%
28 decisions on file.